4D Molecular Therapeutics Inc
FDMT5.195USD
-1.225-19.08%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
240.66MMarket Cap
LossP/E TTM
4D Molecular Therapeutics Inc
5.195
-1.225-19.08%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2019Q4
FY2019Q3
Total revenue
-50.00%14.00K
--1.00K
-99.99%3.00K
-97.91%5.00K
-90.60%28.00K
3940.80%20.20M
47.53%239.00K
-75.55%298.00K
1255.43%1.25M
-63.40%500.00K
-98.89%162.00K
-39.05%1.22M
--92.00K
--1.37M
--14.58M
--2.00M
--2.03M
--540.00K
Revenue
-50.00%14.00K
--1.00K
-99.99%3.00K
-97.91%5.00K
-90.60%28.00K
3940.80%20.20M
47.53%239.00K
-75.55%298.00K
1255.43%1.25M
-63.40%500.00K
-98.89%162.00K
-39.05%1.22M
--92.00K
--1.37M
--14.58M
--2.00M
--2.03M
--540.00K
Operating expenses
40.54%53.63M
--56.12M
49.61%51.13M
31.15%42.46M
25.52%38.16M
26.61%34.18M
13.25%32.38M
10.12%30.40M
20.56%29.97M
12.35%27.00M
28.91%28.59M
50.78%27.61M
--24.86M
--24.03M
--22.18M
--18.31M
--18.32M
--12.43M
R&D expenses
46.03%40.70M
--43.09M
53.53%38.48M
35.09%31.86M
24.35%27.87M
32.34%25.07M
15.48%23.58M
15.64%22.41M
22.66%21.50M
19.57%18.94M
34.15%20.42M
51.78%19.38M
--17.53M
--15.84M
--15.22M
--12.77M
--12.36M
--9.37M
Depreciation, depletion, and amortization
10.04%1.75M
--1.78M
21.99%1.70M
13.73%1.62M
12.89%1.59M
58.82%1.40M
71.84%1.43M
80.56%1.41M
-26.44%1.39M
130.10%879.00K
124.59%831.00K
105.25%782.00K
--1.89M
--382.00K
--370.00K
--381.00K
--318.00K
--300.00K
Operating profit
-40.60%-53.62M
---56.12M
-265.91%-51.13M
-32.11%-42.46M
-26.67%-38.14M
47.26%-13.97M
-13.05%-32.14M
-14.07%-30.11M
-15.97%-28.72M
-16.92%-26.50M
-274.22%-28.43M
-61.79%-26.39M
---24.76M
---22.66M
---7.60M
---16.31M
---16.29M
---11.89M
Net non-operating interest income (expenses)
Non-operating interest income
-2.84%5.58M
--6.47M
88.08%7.29M
200.48%7.55M
298.13%5.75M
387.55%3.88M
638.82%2.51M
1343.00%1.44M
--1.34M
82.76%795.00K
4757.14%340.00K
1328.57%100.00K
----
--435.00K
--7.00K
--7.00K
--218.00K
--341.00K
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
---5.14M
Other non-operating income (expenses)
770.00%67.00K
---21.00K
99.37%-1.00K
-662.50%-45.00K
47.37%-10.00K
-1855.56%-158.00K
--8.00K
58.70%-19.00K
142.86%3.00K
169.23%9.00K
--0.00
54.46%-46.00K
---7.00K
---13.00K
--0.00
---101.00K
---45.00K
--7.00K
Income before tax
-48.06%-47.97M
---49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.40M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
-60.54%-26.34M
---25.08M
---22.24M
---7.59M
---16.41M
---16.11M
---16.68M
Income tax
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-48.06%-47.97M
---49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.40M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
-60.54%-26.34M
---25.08M
---22.24M
---7.59M
---16.41M
---16.11M
---16.68M
Net income from continuous operations
-48.06%-47.97M
---49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.40M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
-60.54%-26.34M
---25.08M
---22.24M
---7.59M
---16.41M
---16.11M
---16.68M
Net income attributable to controlling interests
-48.06%-47.97M
---49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.40M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
-60.54%-26.34M
---25.08M
---22.24M
---7.59M
---16.41M
---16.11M
---16.68M
Net income attributable to common shareholders
-48.06%-47.97M
---49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.40M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
-60.54%-26.34M
---25.08M
---22.24M
---7.59M
---16.41M
---16.11M
---16.68M
Basic earnings per share
-30.87%-0.86
---0.89
-225.16%-0.79
18.16%-0.63
24.97%-0.66
69.40%-0.24
11.09%-0.77
-7.26%-0.88
-2.36%-0.84
3.61%-0.79
-206.14%-0.87
-32.94%-0.82
---0.82
---0.82
---0.28
---0.61
---3.06
---3.17
Diluted earnings per share
-30.87%-0.86
---0.89
-225.16%-0.79
18.16%-0.63
24.97%-0.66
69.40%-0.24
11.09%-0.77
-7.26%-0.88
-2.36%-0.84
3.61%-0.79
-206.14%-0.87
-32.94%-0.82
---0.82
---0.82
---0.28
---0.61
---3.06
---3.17
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
